Effect of 17β-estradiol on diastrophic dysplasia sulfate transporter activity in otosclerotic bone cell cultures and SaOS-2 cells

Acta Oto-Laryngologica

Volumn 124, Issue 8, 2004, Pages 890-895

  Imauchi, Yutaka ^a   Lainé, Pascale ^a   Sterkers, Olivier ^a,b   Ferrary, Evelyne ^a,b   Grayeli, Alexis Bozorg ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

Bone metabolism; Hearing loss; Sex hormones

Indexed keywords

CARRIER PROTEIN; DIASTROPHIC DYSPLASIA SULFATE TRANSPORTER; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; SULFATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE CELL; BONE TURNOVER; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; EXTERNAL AUDITORY CANAL; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; OBSERVATION; OSTEOBLAST; OTOSCLEROSIS; PONS ANGLE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPES; STUDENT T TEST;

ADULT; AGED; ANION TRANSPORT PROTEINS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL LINE; CELLS, CULTURED; EAR CANAL; ESTRADIOL; ESTROGENS; FEMALE; HEARING LOSS; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; OTOSCLEROSIS; RECEPTORS, ESTROGEN; RNA, MESSENGER; STAPES; SULFATES;

EID: 5644246279     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480310017081     Document Type: Article

References (23)

1. Bodo M, Carinci P, Venti G, Giammarioli M, Donti E, Stabellini G, et al. Glycosaminoglycan metabolism and cytokine release in normal and otosclerotic human bone cells interleukin-1 treated. Connect Tissue Res 1997; 36: 231-40.
2. Bodo M, Venti G, Baroni T, Bellucci C, Giammarioli M, Donti E, et al. Phenotype of in vitro human otosclerotic cells and its modulation by TGF β. Cell Mol Biol 1995; 41: 1039-49.
3. Chole RA, McKenna M. Pathophysiology of otosclerosis. Otol Neurotol 2001; 22: 249-57.
4. Locci P, Becchetti E, Venti G, Lilli C, Marinucci L, Donti E, et al. Glycosaminoglycan metabolism in otosclerotic bone cells. Biol Cell 1996; 86: 73-8.
5. Wallis GA. The importance of being sulfated. Curr Biol 1995; 5: 225-7.
6. 2- and sulfur-containing amino acids as sources for macromolecular sulfation. Am J Physiol 1991; 260: L450-6.
7. Hästbacka J, de la Chapelle A, Mahtani MM, Clines G, Reeve-Daly MP, Daly M, et al. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell 1994; 78: 1073-87.
8. Bozorg Grayeli A, Escoubet B, Bichara M, Julien N, Silve C, Friedlander G, et al. Increased activity of the diastrophic dysplasia sulfate transporter (DTDST) in otosclerosis and its inhibition by sodium fluoride. Otol Neurotol 2003; 24: 854-62.
9. Ribari O, Pereplica M, Sziklai I. Oversulfated muccopolysaccharides in the otosclerotic bone. Acta Otolaryngol (Stockh) 1991; 111: 362-5.
10. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996; 11: 1043-51.
11. Elbrond O, Jensen KJ. Otosclerosis and pregnancy: a study of the influence of pregnancy on the hearing threshold before and after stapedectomy. Clin Otolaryngol 1979; 4: 259-66.
12. Bozorg Grayeli A, Sterkers O, Roulleau P, Elbaz P, Ferrary E, Silve C. Parathyroid hormone receptor expression and function in otosclerosis. Am J Physiol 1999; 277: E1005-12.
13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
14. Elgavish A, Smith J, Pillion DJ, Meezan E. Sulfate transport in human lung fibroblasts (IMR-90). J Cell Physiol 1985; 125: 243-50.
15. Satoh H, Susaki M, Shukunami C, Iyama K, Negoro T, Hiraki Y. Functional analysis of diastrophic dysplasia sulfate transporter. Its involvement in growth regulation of chondrocytes mediated by sulfated proteoglycans. J Biol Chem 1998; 273: 12307-15.
16. Bradford MM. A rapid and sensitive method for quantification of microgram quantities of protein using the principle of protein-dose binding. Anal Biochem 1976; 72: 248-52.
17. Rodan SB, Imai Y, Thiede MA, Wesolowski G, Thompson D, Bar-Shavit Z, et al. Characterisation of a human osteosarcoma cell line (SaOS-2) with osteoblastic properties. Cancer Res 1987; 47: 4961-6.
18. Gray TK, Flynn TC, Gray KM, Nabell LM. 17 β-estradiol acts directly on the clonal osteoblastic cell line UMR 106. Proc Natl Acad Sci USA 1987; 84: 6267-71.
19. Ernst M, Heath JK, Rodan GA. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 1989; 125: 825-33.
20. Bord S, Horner A, Beaven S, Compston J. Estrogen receptors α and β are differentially expressed in developing human bone. J Clin Endocrinol Metab 2001; 86: 2309-14.
21. Kobayashi T, Sugimoto T, Saijoh K, Fukase M, Chihara K. Cloning of mouse diastrophic dysplasia transporter gene induced during osteoblast differentiation by bone morphogenetic protein-2. Gene 1997; 198: 341-9.
22. Takeuchi Y, Matsumoto T, Ogata E, Shishiba Y. Isolation and characterization of proteoglycans synthesized by mouse osteoblastic cells in culture during the mineralization process. Biochem J 1990; 266: 15-24.
23. Maurizi M, Binaglia L, Donti E, Ottaviani F, Paludetti G, Venti Donti G. Morphological and functional characteristics of human temporal-bone cell cultures. Cell Tissue Res 1983; 229: 505-13.